MedTrace Logo

PARACHUTE III Pressure Volume Loop Sub-Study

NCT02241837 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2017-06-22

No results posted yet for this study

Summary

The primary objective is to assess the longterm safety of the CardioKinetix Parachute Implant and Delivery System in the partitioning of the left ventricle in patients with heart failure due to ischemic heart disease. This sub-study has the additional assessment of improvement in Pressure Volume Loop and corresponding MSCT to allow improved monitoring of heart improvement after therapy. The PV Loop Substudy studies he effects of the Parachute Implant on pressure and volume as functional parameters of the Left Ventricle.

Conditions

Sponsors & Collaborators

  • CardioKinetix, Inc

    lead INDUSTRY

Principal Investigators

  • Simon Redwood, MD · St. Thomas' Hospital

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-01-31
Completion
2017-06-30

Countries

  • Belgium
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02241837 on ClinicalTrials.gov